Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | HTR2A | P28223 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3371646 | 1.00 | LDHA (0.59) | LDHACA2ALOX15ALOX12SLC6A4 | |
| SCHEMBL2564908 | 1.00 | LDHA (0.59) | LDHACA2ALOX15ALOX12SLC6A4 | |
| SCHEMBL31545634 | 1.00 | LDHA (0.59) | LDHACA2ALOX15ALOX12SLC6A4 | |
| SCHEMBL31545527 | 1.00 | LDHA (0.59) | LDHACA2ALOX15ALOX12SLC6A4 | |
| Hydrochloric Acid SCHEMBL31545361 | 0.98 | LDHA (0.57) | LDHACA2ALOX15ALOX12SLC6A4 | |
| Hydrochloric Acid SCHEMBL8621694 | 0.98 | LDHA (0.57) | LDHACA2ALOX15ALOX12SLC6A4 | |
| Hydrochloric Acid SCHEMBL8867271 | 0.98 | LDHA (0.57) | LDHACA2ALOX15ALOX12SLC6A4 | |
| SCHEMBL5304484 | 0.88 | CALM1 (0.55) | SLC6A4TAAR1KDM4E | |
| SCHEMBL5304491 | 0.88 | CALM1 (0.55) | SLC6A4TAAR1KDM4E | |
| SCHEMBL8635083 | 0.86 | ATM (0.74) | CA2KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4061359-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | Turtle Bear Holdings, LLC (US) | 2022-09-28 | — | — | EP | claimed |
| WO-2021101926-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | STAMETS PAUL EDWARD (US) | 2021-05-27 | — | — | WO | claimed |
| US-20210145851-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | TURTLE BEAR HOLDINGS, LLC | 2021-05-20 | — | — | US | claimed |
| US-20210069170-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | TURTLE BEAR HOLDINGS, LLC | 2021-03-11 | — | — | US | claimed |
| CN-107298655-A | 7,8 dimethoxy 2,3,4,5 tetrahydrochysene 1H benzos [c] azatropylidene hydrochloride and preparation method thereof | 郑州轻工业学院 | 2017-10-27 | — | — | CN | claimed |
| EP-2623593-B1 | NOVEL AMINOTRANSFERASE AND GENE ENCODING SAME, AND USE OF THE AMINOTRANSFERASE AND THE GENE | KANEKA CORP (JP) | 2017-07-12 | — | — | EP | claimed |
| EP-2684953-B1 | MODIFIED AMINOTRANSFERASE, GENE THEREOF, AND METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUND USING SAME | KANEKA CORP (JP) | 2017-06-28 | — | — | EP | claimed |
| EP-2623595-B1 | NOVEL TRANSAMINASE SHOWING HIGH ACTIVITY FOR GLUTAMIC ACID, GENE ENCODING SAME, AND METHOD FOR UTILIZATION THEREOF | KANEKA CORP (JP) | 2016-11-02 | — | — | EP | claimed |
| US-9481870-B2 | Nucleic acid encoding a polypeptide having aminotransferase activity, vectors and host cells comprising the nucleic acid | KANEKA CORPORATION (JP) | 2016-11-01 | — | — | US | claimed |
| WO-2016065425-A1 | BIOTRANSFORMATION REACTIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-05-06 | — | — | WO | claimed |
| EP-2623593-A1 | NOVEL AMINOTRANSFERASE AND GENE ENCODING SAME, AND USE OF THE AMINOTRANSFERASE AND THE GENE | Kaneka Corporation (JP) | 2013-08-07 | — | — | EP | claimed |
| US-20130196389-A1 | NOVEL TRANSAMINASE EXHIBITING HIGH ACTIVITY FOR GLUTAMIC ACID, GENE ENCODING SAME, AND METHOD FOR USING THEM | KANEKA CORPORATION (JP) | 2013-08-01 | — | — | US | claimed |
| EP-0848065-B1 | Method for improving optical purity of an amine compound | SUMITOMO CHEMICAL CO (JP) | 2003-04-02 | — | — | EP | claimed |
| EP-0987332-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | Kaneka Corporation (JP) | 2000-03-22 | — | — | EP | claimed |
| US-5965432-A | PREFERENTIALLY METABOLIZING (S) ENANTOMORPH OF MIXTURE USING CULTURE OF ARTHROBACTER, CULTURE LIQUID, GEL IMMOBILIZED CELLS, FREEZE-DRIED OR ACETONE-DRIED CELLS, GROUND OR AUTODIGESTED CELLS, ULTRASONIC TREATED OR EXTRACTED CELLS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-10-12 | — | — | US | claimed |
| EP-0848065-A2 | Method for improving optical purity of an amine compound | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1998-06-17 | — | — | EP | claimed |
| US-5360724-A | Process for the preparation of chiral 1-aryl-2-aminopropanes | CELGENE CORPORATION (US) | 1994-11-01 | — | — | US | claimed |
| US-4847403-A | 2-Isopropyl-2-(2-methylphenyl)-5-(N-methyl-N-homoveratrylamino)-valeronitrile and method for producing same | SPOFA, SPOJENE PODNIKY PRO ZDRAVOTNICKOU (CS) | 1989-07-11 | — | — | US | claimed |
| EP-0257768-A1 | 2-Isopropyl-2-phenyl-5-(N-methyl-2-phenylethylamino)-valeronitrile derivatives and processes for their preparation | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1988-03-02 | — | — | EP | claimed |
| EP-0142070-B1 | PROCESS FOR THE PREPARATION OF N-METHYLHOMOVERATRYL AMINE | BASF Aktiengesellschaft (DE) | 1986-07-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210145851-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | HTR1B, HTR6, BDNF | LDHA 4842/4885CA2 3926/4885ALOX15 3893/4885 |
| US-20210069170-A1 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | HTR1B, HTR6, BDNF | LDHA 4842/4885CA2 3926/4885ALOX15 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.